Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q3 2016 · 10-Q
Revenue$5.30B$5.30B+3.0% vs Q3 2015 Net Income-$329.00M-$329.00MN/M vs Q3 2015 EPS Diluted-$0.22-$0.22N/M vs Q3 2015 Gross Profit$2,877,000,000+4.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,217,000,000+1.8% Free Cash Flowderived$905,000,000+15.4% Margins · derivedGross margin54.3%+0.7 pt vs Q3 2015
Operating margin16.9%+3.1 pt vs Q3 2015
Net margin-6.2%−17.5 pt vs Q3 2015
ended Sep 30, 2016 · filed Nov 3, 2016 · 34 d after period end